Stock Elyse
Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd.
- Sold, on record
- $6.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 15, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Biohaven Pharmaceutical Holding Co Ltd.Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualOct 15 2019
Sold 800 shares at $45.01 ($36k)
Stock Elyse, Chief Medical Officer
Sold 100% of holdings ($36k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualOct 18 +3 days
Sold 17,700 shares at $45.07 ($798k)
Stock Elyse, Chief Medical Officer
Sold 100% of holdings ($798k position)0 shares leftFiling
- 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 12 +238 days
Sold 36,966 shares at $64.83 ($2.4M)
Stock Elyse, Chief Medical Officer
Sold 95.2% of holdings ($2.5M position)1,844 shares leftFiling
- 4 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualDec 15 +551 days
Sold 28,858 shares at $105.37 ($3M)
Stock Elyse, Chief Medical Officer
Sold 79.4% of holdings ($3.8M position)7,467 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 28,858 | $3M | 79.4% | Unusual | SEC |
| Jun 12, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 36,966 | $2.4M | 95.2% | Unusual | SEC |
| Oct 18, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 17,700 | $798k | 100.0% | Unusual | SEC |
| Oct 15, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 800 | $36k | 100.0% | Unusual | SEC |